Illumina Makes Arbitration Plea In IP Row Over DNA Testing
DNA analysis company Illumina Inc. on Friday tried to sidestep counterclaims from Ariosa Diagnostics Inc. in an ongoing patent fight over a prenatal test for Down Syndrome, telling a Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article